<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Regen</journal-id><journal-id journal-id-type="iso-abbrev">Cell Regen</journal-id><journal-title-group><journal-title>Cell Regeneration</journal-title></journal-title-group><issn pub-type="epub">2045-9769</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39729207</article-id><article-id pub-id-type="pmc">PMC11680512</article-id>
<article-id pub-id-type="publisher-id">217</article-id><article-id pub-id-type="doi">10.1186/s13619-024-00217-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Standard: Human gastric cancer organoids</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tan</surname><given-names>Ronghui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hong</surname><given-names>Fan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhong</surname><given-names>Nanshan</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Hongling</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Rui-hua</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yingbin</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Xuebiao</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Dongxi</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Dong</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Jianping</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Hui</surname><given-names>Lijian</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Zhifeng</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Hao</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Shijun</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Boqiang</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Hua</surname><given-names>Guoqiang</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Zhao-Lei</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chong</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jianmin</given-names></name><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Changlin</given-names></name><xref ref-type="aff" rid="Aff31">31</xref><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chunnian</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Zhan</surname><given-names>Xianbao</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Zhijian</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Chunping</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yingying</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name><surname>Niu</surname><given-names>Gengming</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Yalong</given-names></name><address><email>wangyl16@tsinghua.org.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhao</surname><given-names>Tongbiao</given-names></name><address><email>tbzhao@ioz.ac.cn</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Ye-Guang</given-names></name><address><email>ygchen@tsinghua.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03ybmxt82</institution-id><institution-id institution-id-type="ISNI">0000 0005 0567 8125</institution-id><institution>Guangzhou National Laboratory, </institution></institution-wrap>Guangzhou, 510005 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03cve4549</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution>The State Key Laboratory of Membrane Biology, Tsinghua&#x02011;Peking Center for Life Sciences,, School of Life Sciences
, </institution><institution>Tsinghua University, </institution></institution-wrap>Beijing, 100084 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042v6xz23</institution-id><institution-id institution-id-type="GRID">grid.260463.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2182 8825</institution-id><institution>The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, </institution><institution>Jiangxi Medical College, Nanchang University, </institution></institution-wrap>Nanchang, 330031 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.512959.3</institution-id><institution>Beijing Institute for Stem Cell and Regenerative Medicine, </institution></institution-wrap>Beijing, 100101 China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0400g8r85</institution-id><institution-id institution-id-type="GRID">grid.488530.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1803 6191</institution-id><institution>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, </institution><institution>Sun Yat-Sen University Cancer Center, </institution></institution-wrap>Guangzhou, 510060 China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02drdmm93</institution-id><institution-id institution-id-type="GRID">grid.506261.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 7839</institution-id><institution>Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, </institution><institution>Chinese Academy of Medical Sciences, </institution></institution-wrap>Guangzhou, 510060 China </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00nyxxr91</institution-id><institution-id institution-id-type="GRID">grid.412474.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0027 0586</institution-id><institution>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Oncology, </institution><institution>Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital &#x00026; Institute, </institution></institution-wrap>Beijing, 100142 China </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ty4bg86</institution-id><institution-id institution-id-type="GRID">grid.419087.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1789 563X</institution-id><institution>State Key Laboratory of Systems Medicine for Cancer, </institution><institution>Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, </institution></institution-wrap>Shanghai, 200232 China </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Department of Biliary-Pancreatic Surgery, </institution><institution>Renji HospitalAffiliated to, Shanghai Jiaotong University School of Medicine
, </institution></institution-wrap>Shanghai, 200127 China </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04c4dkn09</institution-id><institution-id institution-id-type="GRID">grid.59053.3a</institution-id><institution-id institution-id-type="ISNI">0000000121679639</institution-id><institution>MOE Key Laboratory of Cellular Dynamics, CAS Center for Excellence in Molecular Cell Science, </institution><institution>University of Science and Technology of China, </institution></institution-wrap>Hefei, 230027 China </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/034t30j35</institution-id><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>Key Laboratory of Multi-Cell Systems, Shanghai Key Laboratory of Molecular Andrology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, 200031 China </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qbk4x57</institution-id><institution-id institution-id-type="GRID">grid.410726.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1797 8419</institution-id><institution>University of Chinese Academy of Sciences, </institution></institution-wrap>Beijing, 100049 China </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00sdcjz77</institution-id><institution-id institution-id-type="GRID">grid.510951.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 7775 6738</institution-id><institution>Institute of Cancer Research, </institution></institution-wrap>Shenzhen Bay Laboratory, Shenzhen, 518132 China </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gbwr869</institution-id><institution-id institution-id-type="GRID">grid.412604.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 4073</institution-id><institution>Department of Oncology, </institution><institution>The First Affiliated Hospital of Nanchang University, </institution></institution-wrap>Nanchang, Jiangxi 330031 China </aff><aff id="Aff15"><label>15</label>Jiangxi Key Laboratory for Individual Cancer Therapy, Nanchang, Jiangxi 330031 China </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/030bhh786</institution-id><institution-id institution-id-type="GRID">grid.440637.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 4657 8879</institution-id><institution>School of Life Science and Technology, Shanghai Tech University, </institution></institution-wrap>Shanghai, 201210 China </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02rrdvm96</institution-id><institution-id institution-id-type="GRID">grid.507739.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0061 254X</institution-id><institution>State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Science, </institution></institution-wrap>Shanghai, 200031 China </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wjghj95</institution-id><institution-id institution-id-type="GRID">grid.412636.4</institution-id><institution>Department of Surgical Oncology and General Surgery, </institution><institution>The First Hospital of China Medical University, </institution></institution-wrap>155N Nanjing Street, Shenyang, Liaoning 110001 China </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00v408z34</institution-id><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution>Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, </institution><institution>China Medical University, </institution></institution-wrap>Shenyang, Liaoning 110001 China </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/032d4f246</institution-id><institution-id institution-id-type="GRID">grid.412449.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9678 1884</institution-id><institution>Institute of Health Sciences, China Medical University, </institution></institution-wrap>Shenyang, Liaoning 110001 China </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/034t30j35</institution-id><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>National Stem Cell Resource Center, Institute of Zoology, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Beijing, 100101 China </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/034t30j35</institution-id><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Beijing, 100101 China </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01vjw4z39</institution-id><institution-id institution-id-type="GRID">grid.284723.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 8877 7471</institution-id><institution>Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People&#x02019;s Hospital (Guangdong Academy of Medical Sciences), </institution><institution>Southern Medical University, </institution></institution-wrap>Guangzhou, 510080 China </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05t8y2r12</institution-id><institution-id institution-id-type="GRID">grid.263761.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0198 0694</institution-id><institution>Department of Cardiovascular Surgery of the First Affiliated Hospital &#x00026; Institute for Cardiovascular Science, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, </institution><institution>Suzhou Medical College, Soochow University, </institution></institution-wrap>Suzhou, 510080 China </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dw0p167</institution-id><institution-id institution-id-type="GRID">grid.419601.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1764 3184</institution-id><institution>National Institute of Metrology, </institution></institution-wrap>Beijing, 100029 China </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00my25942</institution-id><institution-id institution-id-type="GRID">grid.452404.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 0942</institution-id><institution>Department of Radiation Oncology and Cancer Institute, </institution><institution>Fudan University Shanghai Cancer Center Fudan University, </institution></institution-wrap>Shanghai, 200433 China </aff><aff id="Aff27"><label>27</label>D1Med Technology (Shanghai) Inc, Shanghai, 201802 China </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/007mrxy13</institution-id><institution-id institution-id-type="GRID">grid.412901.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1770 1022</institution-id><institution>Gastric Cancer Centerand, Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, </institution><institution>West China Hospital, Sichuan University, </institution></institution-wrap>Chengdu, Sichuan 610041 China </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00nyxxr91</institution-id><institution-id institution-id-type="GRID">grid.412474.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0027 0586</institution-id><institution>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, </institution><institution>Peking University Cancer Hospital &#x00026; Institute, </institution></institution-wrap>Beijing, 100142 China </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02v51f717</institution-id><institution-id institution-id-type="GRID">grid.11135.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2256 9319</institution-id><institution>Peking University International Cancer Institute, Peking University, </institution></institution-wrap>Beijing, 100191 China </aff><aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03qzxj964</institution-id><institution-id institution-id-type="GRID">grid.506899.b</institution-id><institution-id institution-id-type="ISNI">0000 0000 9900 4810</institution-id><institution>China National Institute of Standardization, </institution></institution-wrap>Beijing, 100191 China </aff><aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/032x22645</institution-id><institution-id institution-id-type="GRID">grid.413087.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1755 3939</institution-id><institution>Institute of Clinical Science, </institution><institution>Zhongshan Hospital, Fudan University, </institution></institution-wrap>Shanghai, 200433 China </aff><aff id="Aff33"><label>33</label>Department of Gastrointestinal Pathology, Ningbo Diagnostic Pathology Center, Ningbo, 315021 China </aff><aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02bjs0p66</institution-id><institution-id institution-id-type="GRID">grid.411525.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 1599</institution-id><institution>Department of Oncology, </institution><institution>Changhai Hospital, Second Military Medical University, </institution></institution-wrap>No. 168 Changhai Road, Shanghai, 200433 China </aff><aff id="Aff35"><label>35</label>Huayi Regeneration Technology Co., Ltd, Chengdu, 611135 China </aff><aff id="Aff36"><label>36</label>K2 Oncology Co., Ltd, KeChuang Street, Beijing, 100176 China </aff><aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05w1xct55</institution-id><institution-id institution-id-type="GRID">grid.459748.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 4650 8141</institution-id><institution>Lilly (China) Research and Development Center, </institution></institution-wrap>Shanghai, 201203 China </aff><aff id="Aff38"><label>38</label>Qilu Pharmaceutical Co., Ltd, Jinan, 250104 China </aff><aff id="Aff39"><label>39</label>Shanghai OneTar Biomedicine Co., Ltd, Shanghai, 201203 China </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>33</elocation-id><history><date date-type="received"><day>4</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>10</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Gastric cancer is one of the most common malignancies with poor prognosis. The use of organoids to simulate gastric cancer has rapidly developed over the past several years. Patient-derived gastric cancer organoids serve as in vitro models that closely mimics donor characteristics, offering new opportunities for both basic and applied research. The &#x0201c;Human Gastric Cancer Organoid&#x0201d; is part of a series of guidelines for human gastric cancer organoids in China, jointly drafted by experts from the Chinese Society for Cell Biology and its branches, and initially released on October 29, 2024. This standard outlines terminology, technical requirements, assessment protocols, and applies to production, evaluation procedures, and quality control for human gastric cancer organoids. The publication of this guideline aims to assist institutions in endorsing, establishing, and applying best practices, advancing the international standardization of human gastric cancer organoids for clinical development and therapeutic application.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Standard</kwd><kwd>Human stomach</kwd><kwd>Gastric cancer organoids</kwd><kwd>Terms</kwd><kwd>Definitions</kwd><kwd>Technical requirements</kwd><kwd>Labeling</kwd><kwd>Transportation</kwd><kwd>Storage</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Chinese Society for Cell Biology 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Scope</title><p id="Par10">This document specifies the ethical requirements, technical requirements, and testing methods, inspection rules, usage instructions, labeling, transportation, and storage for human gastric cancer organoids.</p><p id="Par11">This standard applies to the production and test of human gastric cancer derived organoids.</p></sec><sec id="Sec2"><title>Normative references</title><p id="Par12">The following referenced documents are indispensable for the application of these documents. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including all amendments) applies.</p><p id="Par13"><italic>Pharmacopoeia of the People's Republic of China</italic> (2020 Edition, Part III).</p></sec><sec id="Sec3"><title>Terms and definitions</title><p id="Par14">The following terms and definitions apply to this document.</p><sec id="Sec4"><title>Organoids</title><p id="Par15">Three-dimensional (3D) structures that grow from stem cells or progenitor cells in vitro, are capable of self-organization and renewal, consist of organ-specific cell types and can mimic the in vivo architecture and specific function of the original tissue (Clevers <xref ref-type="bibr" rid="CR1">2016</xref>; Kim et al. <xref ref-type="bibr" rid="CR4">2020</xref>; Fujii and Sato <xref ref-type="bibr" rid="CR2">2021</xref>; Lin et al. <xref ref-type="bibr" rid="CR5">2023</xref>).</p></sec><sec id="Sec5"><title>Human gastric cancer organoids</title><p id="Par16">Organoids that develop from gastric tumor cells of patients pathologically diagnosed with gastric cancer, and can simulate the characteristics of original gastric cancer tissues (Fujii et al. <xref ref-type="bibr" rid="CR3">2019</xref>; Seidlitz et al. <xref ref-type="bibr" rid="CR8">2019</xref>; Yan et al. <xref ref-type="bibr" rid="CR12">2018</xref>;&#x000a0;Wang et al. <xref ref-type="bibr" rid="CR11">2024</xref>).</p></sec><sec id="Sec6"><title>Organoid passage</title><p id="Par17">Process of dissociating existing organoids into smaller fragments, or single cell via physical, chemical, or biological methods, and keeping them growing in vitro under the same culture conditions (Seidlitz et al. <xref ref-type="bibr" rid="CR8">2019</xref>).</p></sec><sec id="Sec7"><title>Organoid cryopreservation</title><p id="Par18">Freezing process by which organoids are maintained at low temperature in an inactive state for maintaining cellular composition, gene expression, and functional properties.</p></sec><sec id="Sec8"><title>Organoid thawing</title><p id="Par19">Process of bringing frozen organoids from an inactively to an actively growing state.</p></sec></sec><sec id="Sec9"><title>General requirements</title><sec id="Sec10"><title>Raw materials</title><p id="Par20">The acquisition of raw materials must comply with domestically recognized ethical standards and local laws.</p><p id="Par21">Depending on the intended use, donor evaluation criteria should be established for the research and production of human gastric cancer organoids.</p></sec><sec id="Sec11"><title>Process and information management</title><p id="Par22">Critical factors influencing product quality during the procurement, preparation, testing, transportation, and storage should be documented, and a unique identification system should be implemented to ensure traceability throughout the process.</p><p id="Par23">The minimum retention period for records must be clearly defined to ensure the integrity and security of documentation.</p></sec></sec><sec id="Sec12"><title>Technical requirements</title><sec id="Sec13"><title>Morphology</title><p id="Par24">Human gastric cancer organoids display a variety of morphological characteristics under optical microscopy, including vesicular, compact, and mixed types, among others (Yan et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Seidlitz et al. <xref ref-type="bibr" rid="CR8">2019</xref>, <xref ref-type="bibr" rid="CR9">2020</xref>; Togasaki et al. <xref ref-type="bibr" rid="CR10">2021</xref>; Wang et al. <xref ref-type="bibr" rid="CR11">2024</xref>;).</p></sec><sec id="Sec14"><title>Pathological features</title><p id="Par25">Cells within the organoids should maintain the atypical characteristics of tumor cells found in the original tumor tissue, such as hyperchromatic nuclei, abnormal mitotic figures, and disrupted nuclear-cytoplasmic ratio, etc. (Yan et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Seidlitz et al. <xref ref-type="bibr" rid="CR8">2019</xref>).</p><p id="Par26">Immunohistochemical testing for relevant markers should be performed on the organoids, and the results should be generally consistent with the original tumor tissues. Markers tested include, but are not limited to, CEA and CA19-9 (Yan et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Wang et al. <xref ref-type="bibr" rid="CR11">2024</xref>).</p></sec><sec id="Sec15"><title>Genetic characteristics</title><p id="Par27">Genetic variation testing should be performed on the organoids, and the results should be essentially the same as the genetic variation results of the original tumor tissue. The tested genes shall include, but not be limited to, <italic>TP53</italic>, <italic>ARID1</italic>, <italic>ARBB2</italic>, <italic>MUC6</italic>, <italic>KRAS</italic>, <italic>RHOA</italic>, <italic>RNF43</italic>, <italic>APC</italic>, <italic>CDH1</italic>, and <italic>PIK3CA</italic>, etc. (Fujii et al. <xref ref-type="bibr" rid="CR3">2019</xref>; Togasaki et al. <xref ref-type="bibr" rid="CR10">2021</xref>; Schm&#x000e4;che et al. <xref ref-type="bibr" rid="CR7">2024</xref>; Wang et al. <xref ref-type="bibr" rid="CR11">2024</xref>).</p></sec><sec id="Sec16"><title>Culture and growth</title><p id="Par28">Human gastric cancer organoids derived from gastric cancer patient tissues or cells should be capable of being passaged for at least three generations after the initial culture in vitro (Seidlitz et al. <xref ref-type="bibr" rid="CR8">2019</xref>, <xref ref-type="bibr" rid="CR9">2020</xref>).</p><p id="Par29">Post-passage organoids shall be reconstructed in vitro into new analogous organoids, and their morphology and characteristics shall be consistent with those of the pre-passage organoids (Sato et al. <xref ref-type="bibr" rid="CR6">2011</xref>).</p></sec><sec id="Sec17"><title>Organoids viability</title><p id="Par30">After thawing, the number of viable gastric cancer organoids should be no less than 50% of the number before cryopreservation, and the viable organoids shall be capable of being subcultured in vitro.</p></sec><sec id="Sec18"><title>Microorganisms</title><p id="Par31">Organoids shall be negative for fungi, bacteria, mycoplasma, and virus.</p></sec><sec id="Sec19"><title>Identity</title><p id="Par32">The identity of organoids shall match that of the donor tissue by STR analysis (Yang et al. <xref ref-type="bibr" rid="CR13">2024</xref>).</p></sec></sec><sec id="Sec20"><title>Test methods</title><sec id="Sec21"><title>Morphology</title><p id="Par33">Observe organoid morphology by the inverted phase contrast microscope.</p></sec><sec id="Sec22"><title>Pathological features</title><p id="Par34">The method can be found in <xref rid="Sec36" ref-type="sec">Appendix A</xref>.</p></sec><sec id="Sec23"><title>Genetic characteristics</title><p id="Par35">The method can be found in <xref rid="Sec42" ref-type="sec">Appendix B</xref>.</p></sec><sec id="Sec24"><title>Culture and growth</title><p id="Par36">Organoids cultured in vitro can be photographed using optical microscopy, with a scale bar for measuring their diameter and performing quantitative analysis.</p></sec><sec id="Sec25"><title>Organoids viability</title><p id="Par37">Organoids viability shall be counted according to the method can be found in <xref rid="Sec49" ref-type="sec">Appendix C</xref>.</p></sec><sec id="Sec26"><title>Microorganisms</title><sec id="Sec27"><title>Bacteria and Fungi</title><p id="Par38">The &#x0201c;1101 Sterility Inspection Method&#x0201d; in <italic>Pharmacopoeia of the People's Republic of China</italic> (2020 Edition, Part III) shall be followed.</p></sec><sec id="Sec28"><title>Mycoplasma</title><p id="Par39">The &#x0201c;3301 Mycoplasma Inspection Method&#x0201d; in <italic>Pharmacopoeia of the People's Republic of China</italic> (2020 Edition, Part III) shall be followed.</p></sec><sec id="Sec29"><title>Exogenous viral factors</title><p id="Par40">The &#x0201c;3302 Exogenous Viral Factors Inspection Method&#x0201d; in <italic>Pharmacopoeia of the People's Republic of China</italic> (2020 Edition, Part III) shall be followed.</p></sec></sec><sec id="Sec30"><title>STR</title><p id="Par41">The method can be found in <xref rid="Sec55" ref-type="sec">Appendix D</xref>.</p></sec></sec><sec id="Sec31"><title>Instructions for use</title><p id="Par42">The instructions should include at least the following information:</p><p id="Par43"><list list-type="alpha-lower"><list-item><p id="Par44">Organoid code;</p></list-item><list-item><p id="Par45">Passage number;</p></list-item><list-item><p id="Par46">Organoid number;</p></list-item><list-item><p id="Par47">Production date;</p></list-item><list-item><p id="Par48">Batch number;</p></list-item><list-item><p id="Par49">Manufacturing organization;</p></list-item><list-item><p id="Par50">Storage conditions;</p></list-item><list-item><p id="Par51">Transportation conditions;</p></list-item><list-item><p id="Par52">Contact information;</p></list-item><list-item><p id="Par53">Usage instructions;</p></list-item><list-item><p id="Par54">Standard reference number;</p></list-item><list-item><p id="Par55">Production address;</p></list-item><list-item><p id="Par56">Postal code;</p></list-item><list-item><p id="Par57">Precautions.</p></list-item></list>Note: Endotoxin results should be provided upon user request.</p></sec><sec id="Sec32"><title>Labeling</title><p id="Par58">The labels should include at least the following information:</p><p id="Par59">
<list list-type="alpha-lower"><list-item><p id="Par60">Organoid code;</p></list-item><list-item><p id="Par61">Passage number;</p></list-item><list-item><p id="Par62">Organoid number;</p></list-item><list-item><p id="Par63">Batch number;</p></list-item><list-item><p id="Par64">Manufacturing organization;</p></list-item><list-item><p id="Par65">Production date.</p></list-item></list>
</p></sec><sec id="Sec33"><title>Transportation and storage</title><sec id="Sec34"><title>Transportation</title><p id="Par66">The transportation methods and conditions should be selected based on the requirements for the use of human gastric cancer organoids to ensure their biological properties, safety, stability, and efficacy.</p><p id="Par67">The transportation of human gastric cancer organoids should consider, but not be limited to, factors such as the characteristics of the organoids, the container carrying the organoids, transportation route, conditions, equipment, methods, potential risks, and necessary safeguards.</p><p id="Par68">The control measures for transportation conditions should include, but not be limited to, temperature range, vibration control, contamination prevention, equipment performance, and appropriate packaging.</p><p id="Par69">Relevant inspection and technical guidance documents should be provided upon the user&#x02019;s request.</p><p id="Par70">The package should be checked during transportation, and if necessary, additional freezing sources (e.g., dry ice and liquid nitrogen) should be added to maintain the appropriate transportation temperature.</p></sec><sec id="Sec35"><title>Storage</title><p id="Par71">Optimized cryopreservation protocols and methods should be employed to minimize damage to human gastric cancer organoids during freezing and thawing processes, ensuring their normal functionality is minimally affected.</p><p id="Par72">The cryopreservation information for human gastric cancer organoids should be documented, including but not limited to:</p><p id="Par73">
<list list-type="alpha-lower"><list-item><p id="Par74">Organoid code;</p></list-item><list-item><p id="Par75">Batch number;</p></list-item><list-item><p id="Par76">Organoid number;</p></list-item><list-item><p id="Par77">Passage number;</p></list-item><list-item><p id="Par78">Freezing date;</p></list-item><list-item><p id="Par79">Cryoprotectant composition;</p></list-item><list-item><p id="Par80">Name of the operator.</p></list-item></list>
</p><p id="Par81">The storage conditions for human gastric cancer organoids should be documented, including but not limited to:</p><p id="Par82">
<list list-type="alpha-lower"><list-item><p id="Par83">Storage conditions;</p></list-item><list-item><p id="Par84">Storage date;</p></list-item><list-item><p id="Par85">Storage duration;</p></list-item><list-item><p id="Par86">Storage personnel.</p></list-item></list>
</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec36"><title>Appendix A</title><sec id="Sec37"><title>Organoid Histopathology Test (Paraffin Embedding Method)</title><sec id="Sec38"><title>A.1 Instruments</title><p id="Par90"><italic>A.1.1</italic> Paraffin-embedding machine</p><p id="Par91"><italic>A.1.2</italic> Paraffin-slicer</p></sec><sec id="Sec39"><title>A.2 Reagents</title><p id="Par92">Unless otherwise specified, the reagents used shall be analytically pure, and the water used for testing shall be deionized water.</p><p id="Par93"><italic>A.2.1</italic> Paraffin section preparation reagents: prepare reagents required for paraffin embedding according to the corresponding requirements, including fixing solution, dehydration solution, paraffin, dewaxing solution, rehydration solution, ethanol, xylene, and neutral resin.</p><p id="Par94"><italic>A.2.2</italic> H&#x00026;E staining reagent: hematoxylin, eosin.</p><p id="Par95"><italic>A.2.3</italic> Immunohistochemical staining reagents: prepare antigen repair solution, primary antibody, secondary antibody, blocking buffer, Phosphate buffer saline (PBS), DAB according to the corresponding requirements.</p></sec><sec id="Sec40"><title>A.3 Testing protocol</title><sec id="FPar4"><title>A.3.1 Sample preparation and fixation</title><p id="Par96">The organoids are mechanically pipetted out of Matrigel gently and transferred to a 15 mL centrifuge tube. Collect the organoids by centrifugation and discard the supernatant. The organoids are fixed with 4% paraformaldehyde for 15~30 minutes.</p></sec><sec id="FPar5"><title>A.3.2 Paraffin section preparation of organoids</title><p id="Par97">The organoid samples are fixed, dehydrated, hyalinized, immersed in paraffin, and with a paraffin-embedding machine according to the paraffin-section method. Cut the embedded-paraffin of organoids into standard thickness with paraffin-slicer.</p></sec><sec id="FPar6"><title>A.3.3 H&#x00026;E staining</title><p id="Par98">Paraffin sections of organoids are dewaxed, rehydrated, stained with hematoxylin and eosin, then dehydrated with ethanol, hyalinized by xylene, and sealed by neutral resin.</p></sec><sec id="FPar7"><title>A.3.4 Immunohistochemistry staining</title><p id="Par99">Paraffin sections of organoids are dewaxed, rehydrated, antigen repaired and sealed with blocking solution, and sections are incubated with primary antibody and then cleaned with PBS, followed by incubated with second antibody and cleaned with PBS. Perform the color reaction with DAB and add water to stop the color reaction. The sections are dyed by hematoxylin, hyalinized with hydrochloric acid and flushed, and then dehydrated with ethanol, hyalinized by xylene, and sealed by neutral resin.</p></sec></sec><sec id="Sec41"><title>A.4 Result analysis</title><p id="Par100">The test results obtained are analyzed and judged by personnel qualified for pathological diagnosis, and these results shall be consistent with the results of the original tumor tissue.</p></sec></sec></sec></app><app id="App2"><sec id="Sec42"><title>Appendix B</title><sec id="Sec43"><title>Organoid Gene Mutation Test</title><sec id="Sec44"><title>B.1 Instruments</title><p id="Par101"><italic>B.1.1</italic> Centrifuge</p></sec><sec id="Sec45"><title>B.2 Reagents</title><p id="Par102">Cell DNA extraction kit.</p></sec><sec id="Sec46"><title>B.3 Sample storage</title><p id="Par103">The samples are prepared and stored below -80 &#x02103;.</p></sec><sec id="Sec47"><title>B.4 Testing Protocol</title><sec id="FPar8"><title>B.4.1 Sample preparation</title><p id="Par104">The organoids are cultured in the Matrigel to a stable growth state, and then mechanically pipetted out of the Matrigel. The mixture is collected in a centrifugal tube, the organoids are collected by centrifugation, and the supernatant is discarded.</p></sec><sec id="FPar9"><title>B.4.2 Extraction of DNA</title><p id="Par105">Perform genomic DNA extraction from organoids and primary tumor tissues according to the instructions of the Cell DNA extraction kit.</p></sec><sec id="FPar10"><title>B.4.3 DNA sequencing</title><p id="Par106">Send the organoid DNA samples and original tumor tissues to institutions qualified for clinical genetic testing for 1<sup>st</sup> or 2<sup>nd</sup> generation sequencing testing, or the genetic loci will be tested by amplification refractory mutation system (ARMS) method or droplet digital PCR method.</p></sec></sec><sec id="Sec48"><title>B.5 Result analysis</title><p id="Par107">Analyze the mutant loci and compare the concordance between organoid and original tumor tissue sequencing results.</p></sec></sec></sec></app><app id="App3"><sec id="Sec49"><title>Appendix C</title><sec id="Sec50"><title>Organoids Viability (Calcein-AM Staining Method)</title><sec id="Sec51"><title>C.1 Instruments</title><p id="Par108"><italic>C.1.1</italic> Inverted microscope.</p><p id="Par109"><italic>C.1.2</italic> Fluorescence microscope.</p></sec><sec id="Sec52"><title>C.2 Reagents</title><p id="Par110">Unless otherwise specified, the reagents used shall be analytically pure, and the water used for testing shall be deionized water.</p><p id="Par111"><italic>C.2.1</italic> Dimethyl sulfoxide (DMSO) for cell culture.</p><p id="Par112"><italic>C.2.2</italic> PBS (pH 7.4).</p><p id="Par113"><italic>C.2.3</italic> Storage of Calcein-AM solution: 2 mmol/L in DMSO.</p></sec><sec id="Sec53"><title>C.3 Testing protocol</title><sec id="FPar11"><title>C.3.1 Organoid observation in bright field</title><p id="Par114">Place the organoids under the microscope to observe their morphology and status. Determine whether the organoid morphology meets the requirements of 6.1 by visual observation.</p></sec><sec id="FPar12"><title>C.3.2 Organoid quantification</title><p id="Par115">Add the Calcein-AM storage solution to the medium until the final concentration is 0.2 &#x003bc;mol/L, and incubate the mixture for 60 minutes at 37 &#x02103;. Then clean the medium with Calcein-AM slowly with PBS and add fresh medium. The organoids are observed and photographed by fluorescence microscope at 490 nm excitation wavelength and 515 nm emission wavelength. Living organoids are in green with clear edges. Count the number of organoids with a diameter &#x02265;20 &#x003bc;m.</p></sec></sec><sec id="Sec54"><title>C.4 Accuracy</title><p id="Par116">The absolute difference between the results of three independent determinations obtained under reproducible conditions shall not exceed 10% of the arithmetic mean.</p></sec></sec></sec></app><app id="App4"><sec id="Sec55"><title>Appendix D</title><sec id="Sec56"><title>Organoid Authentication by STR Profile</title><sec id="Sec57"><title>D.1 Instruments</title><p id="Par117"><italic>D.1.1</italic> Centrifuge.</p><p id="Par118"><italic>D.1.2</italic> PCR-Cycler.</p><p id="Par119"><italic>D.1.3</italic> Electrophoresis apparatus.</p><p id="Par120"><italic>D.1.4</italic> Microvolume UV Spectrophotometer.</p></sec><sec id="Sec58"><title>D.2 Reagents</title><p id="Par121"><italic>D.2.1</italic> Cell DNA extraction kit.</p><p id="Par122"><italic>D.2.2</italic> STR DNA profiling kit.</p></sec><sec id="Sec59"><title>D.3 Sample storage</title><p id="Par123">The samples are prepared and stored below -80 &#x02103;.</p></sec><sec id="Sec60"><title>D.4 Testing protocol</title><sec id="FPar13"><title>D.4.1 Sample preparation</title><p id="Par124">The organoids are cultured in the Matrigel to a stable growth state, and then mechanically pipetted out of the Matrigel. The mixture is collected in a centrifugal tube, the organoids are collected by centrifugation, and the supernatant is discarded.</p></sec><sec id="FPar14"><title>D.4.2 Extraction of DNA</title><p id="Par125">
<list list-type="simple"><list-item><label>A)</label><p id="Par126">Perform genomic DNA extraction from organoids and primary tumor tissues according to the instructions of the Cell DNA extraction kit.</p></list-item><list-item><label>B)</label><p id="Par127">Measure the absorbance of extracted DNA by UV spectrophotometer to ensure that the ratio of A260/A280 is between 1.8 and 2.0.</p></list-item><list-item><label>C)</label><p id="Par128">DNA volume &#x02265; 20 &#x003bc;L, DNA concentration &#x02265; 50 ng/&#x003bc;L.</p></list-item></list>
</p></sec><sec id="FPar15"><title>D.4.3 PCR amplification</title><p id="Par129">
<list list-type="simple"><list-item><label>A)</label><p id="Par130">Perform STR DNA amplification according to standard PCR amplification methods or the commercially approved kit instructions.</p></list-item><list-item><label>B)</label><p id="Par131">Use sterile water as the template for PCR amplification in the negative control group; use the DNA extracted from organoid and primary tumor tissue samples as a template for PCR amplification in the sample detection group; use a DNA template with a confirmed STR profiling as the positive control group.</p></list-item><list-item><label>C)</label><p id="Par132">Detect the PCR products of three groups by agarose gel electrophoresis. Clear target band shall be observed in the positive control but not in the negative control.</p></list-item></list>
</p></sec><sec id="FPar16"><title>B.4.4 STR genotyping</title><p id="Par133">Detect PCR products by capillary electrophoresis gene analyzer and STR genetic map data are obtained. The PCR banding pattern of organoids and primary tumor tissue shall be consistent.</p></sec></sec><sec id="Sec61"><title>D.5 Result analysis</title><p id="Par134"><italic>D.5.1</italic> When STR alleles contain the same number of repeats, only one allele peak shall appear in the profile, when they contain different numbers of repeats, two allele peaks appear in the profile. The test is considered valid when no allele peaks appeared in the negative control group and the positive control group is consistent with its standard genotyping data.</p><p id="Par135"><italic>D.5.2</italic> If more than two allelic peaks are present at the STR locus of the tested sample, the sample shall be determined to be cross-contaminated after repeated experiments to exclude interfering factors such as mutations in the primer binding region, provided that the test is valid.</p></sec></sec></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>3D</term><def><p id="Par2">Three Dimension</p></def></def-item><def-item><term>DAB</term><def><p id="Par3">Diaminobenzidine</p></def></def-item><def-item><term>DMSO</term><def><p id="Par4">Dimethyl Sulfoxide</p></def></def-item><def-item><term>DNA</term><def><p id="Par5">Deoxyribonucleic Acid</p></def></def-item><def-item><term>H&#x00026;E</term><def><p id="Par6">Hematoxylin and Eosin</p></def></def-item><def-item><term>PBS</term><def><p id="Par7">Phosphate Buffer Saline</p></def></def-item><def-item><term>PCR</term><def><p id="Par8">Polymerase Chain Reaction</p></def></def-item><def-item><term>STR</term><def><p id="Par9">Short Tandem Repeat</p></def></def-item></def-list></glossary><fn-group><fn><p>Ronghui Tan, Fan Hong, Ting Wang and Nanshan Zhong contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Prof. Ka Li, Aijin Ma, Qiyuan Li, Junying Yu, Yong Zhang for offering suggestions.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Y.-G.C. and T.Z. contributed to conception and design. R.T., F.H., T.W., Y.W. and N.Z. drafted and revised the manuscript. Y.W., H.Z., R.-H.X., L.S., Y.L. (Yingbin Liu), X.Y., D.X., L.H., J.X., D.G., Z.M., B.Z., J.H., Y.L. (Yong Li), S.H., B.F., G.H., L.W., Z.-L.Z., C.C., J.W., C.W. (Changlin Wang), C.W. (Chunnian Wang), X.Z., C.S., Z.S, C.Y., Y.Y. and&#x000a0;G.N. critically read and revised the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by grants from the National Natural Science Foundation of China (31988101 to Y.&#x02011;G.C., 32300586 to Y.L.W.), the National Key Research and Development Program of China (2023YFA1800603 to Y.&#x02011;G.C), Major Project of Guangzhou National Laboratory (GZNL2023A02008 to Y.L.W.), and Young Talent Support Project of Guangzhou Association for Science and Technology (QT2024&#x02011;019 to Y.L.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data needed to evaluate the conclusions in the paper are present in the paper.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par87">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par88">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par89">Y.-G.C. is the Editor&#x02011;in&#x02011;Chief of Cell Regeneration. He was not involved in the review or decision related to this manuscript. This work was not sponsored by any commercial organizations, and all the other authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References
</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Modeling Development and Disease with Organoids</article-title><source>Cell</source><year>2016</year><volume>165</volume><issue>7</issue><fpage>1586</fpage><lpage>1597</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.082</pub-id><pub-id pub-id-type="pmid">27315476</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Clevers H. Modeling Development and Disease with Organoids. Cell. 2016;165(7):1586&#x02013;97. 10.1016/j.cell.2016.05.082.<pub-id pub-id-type="pmid">27315476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group><article-title>Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases</article-title><source>Nat Mater</source><year>2021</year><volume>20</volume><issue>2</issue><fpage>156</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1038/s41563-020-0754-0</pub-id><pub-id pub-id-type="pmid">32807924</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Fujii M, Sato T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat Mater. 2021;20(2):156&#x02013;69. 10.1038/s41563-020-0754-0.<pub-id pub-id-type="pmid">32807924</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group><article-title>Modeling Human Digestive Diseases With CRISPR-Cas9&#x02013;Modified Organoids</article-title><source>Gastroenterology</source><year>2019</year><volume>156</volume><issue>3</issue><fpage>562</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2018.11.048</pub-id><pub-id pub-id-type="pmid">30476497</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Fujii M, Clevers H, Sato T. Modeling Human Digestive Diseases With CRISPR-Cas9&#x02013;Modified Organoids. Gastroenterology. 2019;156(3):562&#x02013;76. 10.1053/j.gastro.2018.11.048.<pub-id pub-id-type="pmid">30476497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><article-title>Human organoids: model systems for human biology and medicine</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><issue>10</issue><fpage>571</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0259-3</pub-id><pub-id pub-id-type="pmid">32636524</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571&#x02013;84. 10.1038/s41580-020-0259-3.<pub-id pub-id-type="pmid">32636524</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><mixed-citation publication-type="other">Lin H, Wang Y, Cheng C, Qian Y, Hao J, Zhang Z, et al. Standard:&#x000a0;Human intestinal cancer organoids. Cell Regeneration. 2023;12(1). 10.1186/s13619-023-00167-6.</mixed-citation></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Ferrante</surname><given-names>M</given-names></name><name><surname>Vries</surname><given-names>RGJ</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>van den Brink</surname><given-names>S</given-names></name><etal/></person-group><article-title>Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium</article-title><source>Gastroenterology</source><year>2011</year><volume>141</volume><issue>5</issue><fpage>1762</fpage><lpage>1772</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.07.050</pub-id><pub-id pub-id-type="pmid">21889923</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Sato T, Stange DE, Ferrante M, Vries RGJ, van Es JH, van den Brink S, et al. Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett&#x02019;s Epithelium. Gastroenterology. 2011;141(5):1762&#x02013;72. 10.1053/j.gastro.2011.07.050.<pub-id pub-id-type="pmid">21889923</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><mixed-citation publication-type="other">Schm&#x000e4;che T, Fohgrub J, Klimova A, Laaber K, Drukewitz S, Merboth F, et al. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold. Molecular Cancer. 2024;23(1). 10.1186/s12943-023-01919-3.</mixed-citation></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Seidlitz</surname><given-names>T</given-names></name><name><surname>Merker</surname><given-names>SR</given-names></name><name><surname>Rothe</surname><given-names>A</given-names></name><name><surname>Zakrzewski</surname><given-names>F</given-names></name><name><surname>von Neubeck</surname><given-names>C</given-names></name><name><surname>Gr&#x000fc;tzmann</surname><given-names>K</given-names></name><etal/></person-group><article-title>Human gastric cancer modelling using organoids</article-title><source>Gut</source><year>2019</year><volume>68</volume><issue>2</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2017-314549</pub-id><pub-id pub-id-type="pmid">29703791</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Gr&#x000fc;tzmann K, et al. Human gastric cancer modelling using organoids. Gut. 2019;68(2):207&#x02013;17. 10.1136/gutjnl-2017-314549.<pub-id pub-id-type="pmid">29703791</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Seidlitz</surname><given-names>T</given-names></name><name><surname>Koo</surname><given-names>B-K</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name></person-group><article-title>Gastric organoids&#x02014;an <italic>in vitro</italic> model system for the study of gastric development and road to personalized medicine</article-title><source>Cell Death Differ</source><year>2020</year><volume>28</volume><issue>1</issue><fpage>68</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00662-2</pub-id><pub-id pub-id-type="pmid">33223522</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Seidlitz T, Koo B-K, Stange DE. Gastric organoids&#x02014;an <italic>in vitro</italic> model system for the study of gastric development and road to personalized medicine. Cell Death Differ. 2020;28(1):68&#x02013;83. 10.1038/s41418-020-00662-2.<pub-id pub-id-type="pmid">33223522</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Togasaki</surname><given-names>K</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Ohta</surname><given-names>Y</given-names></name><name><surname>Nanki</surname><given-names>K</given-names></name><name><surname>Matano</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer</article-title><source>Gastroenterology</source><year>2021</year><volume>160</volume><issue>3</issue><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2020.10.047</pub-id><pub-id pub-id-type="pmid">33217450</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Togasaki K, Sugimoto S, Ohta Y, Nanki K, Matano M, Takahashi S, et al. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer. Gastroenterology. 2021;160(3):823&#x02013;30. 10.1053/j.gastro.2020.10.047.<pub-id pub-id-type="pmid">33217450</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><mixed-citation publication-type="other">Wang T, Song W, Meng Q, Qu C, Guo S, Wang Y, et al. Tumorigenicity and prediction of clinical prognosis of patient&#x02010;derived gastric cancer organoids. Clinical and Translational Medicine. 2024;14(2). 10.1002/ctm2.1588.</mixed-citation></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>HHN</given-names></name><name><surname>Siu</surname><given-names>HC</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>SL</given-names></name><name><surname>Yue</surname><given-names>SSK</given-names></name><name><surname>Tsui</surname><given-names>WY</given-names></name><etal/></person-group><article-title>A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening</article-title><source>Cell Stem Cell</source><year>2018</year><volume>23</volume><issue>6</issue><fpage>882</fpage><lpage>97.e11</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.09.016</pub-id><pub-id pub-id-type="pmid">30344100</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. Cell Stem Cell. 2018;23(6):882-97.e11. 10.1016/j.stem.2018.09.016.<pub-id pub-id-type="pmid">30344100</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Kwan</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Zang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine</article-title><source>J Transl Med</source><year>2024</year><volume>22</volume><issue>1</issue><fpage>754</fpage><pub-id pub-id-type="doi">10.1186/s12967-024-05512-0</pub-id><pub-id pub-id-type="pmid">39135062</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Yang R, Qi Y, Kwan W, Du Y, Yan R, Zang L, et al. Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine. J Transl Med. 2024;22(1):754. 10.1186/s12967-024-05512-0.<pub-id pub-id-type="pmid">39135062</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>